Understanding how immune cells process and respond to different types of particles

High-dimensional characterization of phagosome composition, control and phagocytic receptor redundancy

NIH-funded research Massachusetts General Hospital · NIH-11086810

This study looks at how certain immune cells called phagocytes eat up germs and dead cells, helping us understand how they work better, which could lead to new treatments for people with immune system issues.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11086810 on NIH RePORTER

What this research studies

This research investigates the complex processes by which immune cells, known as phagocytes, engulf and process various particles, including pathogens and dead cells. It focuses on the formation and maturation of phagosomes, which are specialized compartments within these cells that help break down and manage the engulfed material. By examining the biochemical environment and signaling pathways involved, the study aims to provide a comprehensive view of how these processes influence immune responses. Patients may benefit from insights gained into immune function and potential therapeutic targets for diseases related to immune system dysfunction.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include individuals with immune-related conditions or those undergoing treatments that affect immune function.

Not a fit: Patients with non-immune related conditions or those not experiencing any immune dysfunction may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for conditions involving immune system dysfunction, such as infections and autoimmune diseases.

How similar studies have performed: Previous research has shown success in understanding phagocytosis and immune responses, but this study aims to provide a novel, integrated systems-level perspective.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.